Drug profile · INN
tegafur
TEYSUNO
tegafur (TEYSUNO) is a thymidylate synthase inhibitor.
EMA: approved Antineoplastic and immunomodulating agents (L01) L01BC53
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — tegafur
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.83
Quick answer
tegafur (TEYSUNO) is a thymidylate synthase inhibitor.
Key facts
INN tegafur
Brand TEYSUNO
Mechanism Thymidylate synthase inhibitor
Target DNA
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01BC53
Mechanism of action
Thymidylate synthase inhibitor
Primary target: DNA
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tegafur?
tegafur (TEYSUNO) is a thymidylate synthase inhibitor.
What is the brand name for tegafur?
TEYSUNO is a marketed brand name for tegafur. Check FDA Drugs@FDA for the current US label holder and prescribing information.